SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas Stewart who wrote (22)3/6/1997 8:27:00 PM
From: stantheman   of 298
 
Tom: Don't you think that the neurologists will prescribe the oral med to all their MS patients even if the study only suggests a slight improvement in exacerbation frequency in a subgroup of MS patients; extrapolating the results to all their patients. It really does seem like a "no-brainer"! To be able to offer a pill with a low side effect spectrum for this debilitating disease seems like quite a feat.(Almost as incredible as a pill for impotence<VBG>).Back to lurking....ST
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News